In this presentation from the JAK Inhibitors in Myeloproliferative Neoplasms symposium, held August 27, 2016 in Alexandria, VA, Dr. Stephen T. Oh examines whether or not JAK inhibitors have a role to play in the treatment of essential thrombocythemia (ET).
Is there a role for JAK inhibitors in Essential Thrombocythemia (ET)?
